BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23666674)

  • 1. Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere.
    Cheng Y; Wan X; McElfresh TA; Chen X; Gresham KS; Rosenbaum DS; Chandler MP; Stelzer JE
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H52-65. PubMed ID: 23666674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.
    Mamidi R; Gresham KS; Li A; dos Remedios CG; Stelzer JE
    J Mol Cell Cardiol; 2015 Aug; 85():262-72. PubMed ID: 26100051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2.
    Kunst G; Kress KR; Gruen M; Uttenweiler D; Gautel M; Fink RH
    Circ Res; 2000 Jan 7-21; 86(1):51-8. PubMed ID: 10625305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A post-MI power struggle: adaptations in cardiac power occur at the sarcomere level alongside MyBP-C and RLC phosphorylation.
    Toepfer CN; Sikkel MB; Caorsi V; Vydyanath A; Torre I; Copeland O; Lyon AR; Marston SB; Luther PK; Macleod KT; West TG; Ferenczi MA
    Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H465-75. PubMed ID: 27233767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two murine models of familial hypertrophic cardiomyopathy.
    McConnell BK; Fatkin D; Semsarian C; Jones KA; Georgakopoulos D; Maguire CT; Healey MJ; Mudd JO; Moskowitz IP; Conner DA; Giewat M; Wakimoto H; Berul CI; Schoen FJ; Kass DA; Seidman CE; Seidman JG
    Circ Res; 2001 Mar; 88(4):383-9. PubMed ID: 11230104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.
    Gresham KS; Stelzer JE
    J Physiol; 2016 Feb; 594(3):669-86. PubMed ID: 26635197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo cardiac myosin binding protein C gene transfer rescues myofilament contractile dysfunction in cardiac myosin binding protein C null mice.
    Merkulov S; Chen X; Chandler MP; Stelzer JE
    Circ Heart Fail; 2012 Sep; 5(5):635-44. PubMed ID: 22855556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
    O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
    J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of myofilament force and loaded shortening by skeletal myosin binding protein C.
    Robinett JC; Hanft LM; Geist J; Kontrogianni-Konstantopoulos A; McDonald KS
    J Gen Physiol; 2019 May; 151(5):645-659. PubMed ID: 30705121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice.
    Harris SP; Bartley CR; Hacker TA; McDonald KS; Douglas PS; Greaser ML; Powers PA; Moss RL
    Circ Res; 2002 Mar; 90(5):594-601. PubMed ID: 11909824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcomeric protein modification during adrenergic stress enhances cross-bridge kinetics and cardiac output.
    Gresham KS; Mamidi R; Li J; Kwak H; Stelzer JE
    J Appl Physiol (1985); 2017 Mar; 122(3):520-530. PubMed ID: 27909224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation.
    Scruggs SB; Hinken AC; Thawornkaiwong A; Robbins J; Walker LA; de Tombe PP; Geenen DL; Buttrick PM; Solaro RJ
    J Biol Chem; 2009 Feb; 284(8):5097-106. PubMed ID: 19106098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
    De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
    J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C.
    Witt CC; Gerull B; Davies MJ; Centner T; Linke WA; Thierfelder L
    J Biol Chem; 2001 Feb; 276(7):5353-9. PubMed ID: 11096095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction.
    van Dijk SJ; Dooijes D; dos Remedios C; Michels M; Lamers JM; Winegrad S; Schlossarek S; Carrier L; ten Cate FJ; Stienen GJ; van der Velden J
    Circulation; 2009 Mar; 119(11):1473-83. PubMed ID: 19273718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant Myosin-binding protein C gene.
    Berul CI; McConnell BK; Wakimoto H; Moskowitz IP; Maguire CT; Semsarian C; Vargas MM; Gehrmann J; Seidman CE; Seidman JG
    Circulation; 2001 Nov; 104(22):2734-9. PubMed ID: 11723028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar function.
    Hanft LM; Cornell TD; McDonald CA; Rovetto MJ; Emter CA; McDonald KS
    Arch Biochem Biophys; 2016 Jul; 601():22-31. PubMed ID: 26854722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.
    McConnell BK; Jones KA; Fatkin D; Arroyo LH; Lee RT; Aristizabal O; Turnbull DH; Georgakopoulos D; Kass D; Bond M; Niimura H; Schoen FJ; Conner D; Fischman DA; Seidman CE; Seidman JG
    J Clin Invest; 1999 Nov; 104(9):1235-44. PubMed ID: 10545522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of cardiac myosin-binding protein-C contributes to calcium homeostasis.
    Kumar M; Haghighi K; Kranias EG; Sadayappan S
    J Biol Chem; 2020 Aug; 295(32):11275-11291. PubMed ID: 32554466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy.
    Helms AS; Tang VT; O'Leary TS; Friedline S; Wauchope M; Arora A; Wasserman AH; Smith ED; Lee LM; Wen XW; Shavit JA; Liu AP; Previs MJ; Day SM
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.